Seeking to fill gap in the clinic, LSP raises €50M toward dementia-focused fund

European investment firm LSP has launched a new dementia-focused fund to fill what it believes is a gap in support for development-stage companies evaluating treatments for neurodegenerative diseases.

The firm has named Philip Scheltens, who is director of the Alzheimer’s research center at VU University Medical Center in Amsterdam, to manage the fund...